Literature DB >> 3596806

Role of volatile fatty acids in colonization resistance to Clostridium difficile in gnotobiotic mice.

W J Su, M J Waechter, P Bourlioux, M Dolegeal, J Fourniat, G Mahuzier.   

Abstract

Clostridium difficile is an agent involved in the development of antibiotic-associated pseudomembranous colitis. The purpose of this work was to investigate the role of volatile fatty acids (VFAs) in resistance to colonization by C. difficile by using a gnotobiotic animal model. Accordingly, germfree mice were associated with different hamster flora, and the VFAs in their cecal contents were measured by gas chromatography. The results showed that VFAs were produced mainly by the intestinal flora, especially by the strictly anaerobic bacteria. In these associated mice, the concentrations of acetic, propionic, and butyric acids were higher than those of other acids, but at pH 6.8 the MICs of these three acids in vitro for C. difficile were more than 200 mu eq/ml. In gnotobiotic mice monoassociated with C. difficile and in the isolated ceca of these mice, VFAs did not inhibit the growth of C. difficile. In gnotobiotic mice which were diassociated with C. difficile and C. butyricum and given drinking water with a lactose concentration of 20%, the cecal contents included about the same amount of butyric acid as did those of the monoassociated mice, although the population of C. difficile remained the same. Therefore, it is suggested that VFAs alone cannot inhibit intestinal colonization by C. difficile and that, consequently, other inhibitory mechanisms are also present.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3596806      PMCID: PMC260579          DOI: 10.1128/iai.55.7.1686-1691.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Pseudomembranous colitis following aureomycin and chloramphenicol.

Authors:  L REINER; M J SCHLESINGER; G M MILLER
Journal:  AMA Arch Pathol       Date:  1952-07

2.  Purification and characterization of toxins A and B of Clostridium difficile.

Authors:  N M Sullivan; S Pellett; T D Wilkins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

3.  Changes in the mouse intestinal microflora during weaning: role of volatile fatty acids.

Authors:  A Lee; E Gemmell
Journal:  Infect Immun       Date:  1972-01       Impact factor: 3.441

4.  Effect of colon flora and short-chain fatty acids on growth in vitro of Pseudomonas aeruginsoa and Enterobacteriaceae.

Authors:  M E Levison
Journal:  Infect Immun       Date:  1973-07       Impact factor: 3.441

5.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

6.  [Evaluation of an experimental animal model allowing the study of the cecal microflora in the hamster, antagonistic to clostridium difficile].

Authors:  W J Su; P Bourlioux; M Bournaud; M O Besnier; J Fourniat
Journal:  Ann Inst Pasteur Microbiol (1985)       Date:  1986 Jan-Feb

7.  Clindamycin-induced enterocolitis in hamsters.

Authors:  R H Lusk; R Fekety; J Silva; R A Browne; D H Ringler; G D Abrams
Journal:  J Infect Dis       Date:  1978-04       Impact factor: 5.226

8.  Role of volatile fatty acids in colonization resistance to Clostridium difficile.

Authors:  R D Rolfe
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

9.  RESISTANCE OF THE MOUSE'S INTESTINAL TRACT TO EXPERIMENTAL SALMONELLA INFECTION. I. FACTORS WHICH INTERFERE WITH THE INITIATION OF INFECTION BY ORAL INOCULATION.

Authors:  M BOHNHOFF; C P MILLER; W R MARTIN
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

10.  Inhibition of Shigella flexneri by the Normal Intestinal Flora III. Interactions with Bacteroides fragilis Strains in Vitro.

Authors:  D J Hentges; B R Maier
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

View more
  11 in total

1.  Trametes versicolor extract modifies human fecal microbiota composition in vitro.

Authors:  Zhuo-Teng Yu; Bo Liu; Purna Mukherjee; David S Newburg
Journal:  Plant Foods Hum Nutr       Date:  2013-06       Impact factor: 3.921

2.  Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea.

Authors:  Vijay C Antharam; Eric C Li; Arif Ishmael; Anuj Sharma; Volker Mai; Kenneth H Rand; Gary P Wang
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

3.  Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae.

Authors:  Angela E Reeves; Mark J Koenigsknecht; Ingrid L Bergin; Vincent B Young
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

4.  Effect of an oxygen-tolerant bifurcating butyryl coenzyme A dehydrogenase/electron-transferring flavoprotein complex from Clostridium difficile on butyrate production in Escherichia coli.

Authors:  El-Hussiny Aboulnaga; Olaf Pinkenburg; Johannes Schiffels; Ahmed El-Refai; Wolfgang Buckel; Thorsten Selmer
Journal:  J Bacteriol       Date:  2013-06-14       Impact factor: 3.490

Review 5.  The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance.

Authors:  Melinda M Pettigrew; J Kristie Johnson; Anthony D Harris
Journal:  Ann Epidemiol       Date:  2016-03-08       Impact factor: 3.797

6.  Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora.

Authors:  K H Wilson; F Perini
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

7.  Time-resolved amino acid uptake of Clostridium difficile 630Δerm and concomitant fermentation product and toxin formation.

Authors:  Meina Neumann-Schaal; Julia Danielle Hofmann; Sabine Eva Will; Dietmar Schomburg
Journal:  BMC Microbiol       Date:  2015-12-18       Impact factor: 3.605

Review 8.  Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections.

Authors:  Amoe Baktash; Elisabeth M Terveer; Romy D Zwittink; Bastian V H Hornung; Jeroen Corver; Ed J Kuijper; Wiep Klaas Smits
Journal:  Front Microbiol       Date:  2018-06-12       Impact factor: 5.640

Review 9.  Role of microbiota and innate immunity in recurrent Clostridium difficile infection.

Authors:  Stefano Bibbò; Loris Riccardo Lopetuso; Gianluca Ianiro; Teresa Di Rienzo; Antonio Gasbarrini; Giovanni Cammarota
Journal:  J Immunol Res       Date:  2014-06-05       Impact factor: 4.818

Review 10.  Colonization Resistance of the Gut Microbiota against Clostridium difficile.

Authors:  Ana Elena Pérez-Cobas; Andrés Moya; María José Gosalbes; Amparo Latorre
Journal:  Antibiotics (Basel)       Date:  2015-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.